Matthaios Katsaras

Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis

Τheodoros Karampitsakos, Sebastiano Emanuele Torrisi, Effrosyni D. Manali et al. · Respiratory Research · 2021 · 69 citations · Full text

Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis

Αrgyris Τzouvelekis, Τheodoros Karampitsakos, Sofia Kourtidou et al. · Frontiers in Medicine · 2020 · 54 citations · Full text

Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial

Τheodoros Karampitsakos, Panagiota Tsiri, Matthaios Katsaras et al. · Clinical Microbiology and Infection · 2022 · 42 citations · Full text

Open Label, Tocilizumab Versus Baricitinib, Clinical Infectious Disease +7

Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis

Τheodoros Karampitsakos, Apostolos Galaris, Serafeim Chrysikos et al. · Respiratory Research · 2023 · 27 citations · Full text

Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model

Τheodoros Karampitsakos, Vasilina Sotiropoulou, Matthaios Katsaras et al. · Frontiers in Medicine · 2023 · 21 citations · Full text